Iterum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(0%),Point72 Capital Advisors, Inc.(0%)等
Iterum Therapeutics | SC 13G:超过5%持股股东披露文件-Armistice Capital, LLC(6.03%),Steven Boyd(6.03%)
Iterum Therapeutics | 4:持股变动声明-董事 Dunne Michael W.
Iterum Therapeutics | 4:持股变动声明-高管 Fishman Corey N.
Iterum Therapeutics | 4:持股变动声明-董事 HUNT RONALD
Iterum Therapeutics | SC 13G:超过5%持股股东披露文件-Point72 Asset Management, L.P.(6.3%),Point72 Capital Advisors, Inc.(6.3%)等
Iterum Therapeutics | 4:持股变动声明-董事 Dunne Michael W.
Iterum Therapeutics | 4:持股变动声明-董事 Dunne Michael W.
Iterum Therapeutics | 4:持股变动声明-高管 Puttagunta Sailaja
Iterum Therapeutics | 4:持股变动声明-董事 Dunne Michael W.
Iterum Therapeutics | 4:持股变动声明-首席执行官 Fishman Corey N.
Iterum Therapeutics | 4:持股变动声明-董事 HUNT RONALD
Iterum Therapeutics | 4:持股变动声明-董事 Dunne Michael W.
Iterum Therapeutics | 4:持股变动声明-董事 Dunne Michael W.
Iterum Therapeutics | 4:持股变动声明-董事 HUNT RONALD
Iterum Therapeutics | 4:持股变动声明-董事 Hecht Beth
Iterum Therapeutics | 4:持股变动声明-董事 Dunne Michael W.
Iterum Therapeutics | 4:持股变动声明-董事 Chin Mark
Iterum Therapeutics | 4/A:持股变动声明(修正)-董事 Dunne Michael W.
Iterum Therapeutics | 4:持股变动声明-董事 HUNT RONALD